Westpac Banking Corp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.37M Sell
38,870
-2,811
-7% -$269K 0.23% 105
2025
Q4
$4M Buy
41,681
+4,174
+11% +$405K 0.25% 97
2025
Q3
$3.57M Buy
37,507
+34,673
+1,223% +$3.19M 0.22% 107
2025
Q2
$247K Sell
2,834
-1,573
-36% -$133K 0.02% 324
2025
Q1
$396K Sell
4,407
-97
-2% -$8.68K 0.03% 273
2024
Q4
$360K Sell
4,504
-111
-2% -$9.61K 0.02% 307
2024
Q3
$415K Buy
4,615
+1,613
+54% +$136K 0.03% 293
2024
Q2
$236K Buy
+3,002
New +$246K 0.02% 315
2023
Q2
Sell
-112,323
Closed -$9.06M 670
2023
Q1
$9.06M Sell
112,323
-2,500
-2% -$204K 0.12% 211
2022
Q4
$8.92M Buy
114,823
+463
+0.4% +$37.5K 0.13% 199
2022
Q3
$9.23M Sell
114,360
-1,234
-1% -$111K 0.14% 196
2022
Q2
$10.4M Sell
115,594
-3,614
-3% -$366K 0.14% 204
2022
Q1
$13.2M Hold
119,208
0.15% 174
2021
Q4
$12.3M Sell
119,208
-35,998
-23% -$4.17M 0.13% 199
2021
Q3
$19.5M Sell
155,206
-6,711
-4% -$869K 0.21% 117
2021
Q2
$20.1M Buy
+161,917
New +$20.3M 0.2% 127
2021
Q1
Sell
-151,896
Closed -$17.8M 820
2020
Q4
$17.8M Buy
151,896
+13,501
+10% +$1.49M 0.2% 125
2020
Q3
$14.4M Sell
138,395
-1,575
-1% -$158K 0.19% 132
2020
Q2
$12.8M Sell
139,970
-26,811
-16% -$2.57M 0.19% 133
2020
Q1
$15M Buy
166,781
+20,363
+14% +$2.17M 0.26% 101
2019
Q4
$16.6M Sell
146,418
-201
-0.1% -$22.1K 0.21% 126
2019
Q3
$15.9M Buy
+146,619
New +$15.3M 0.22% 121
2019
Q1
Sell
-452,672
Closed -$41.2M 779
2018
Q4
$41.2M Buy
+452,672
New +$42.3M 0.7% 19
2017
Q4
Sell
-412,410
Closed -$32.1M 749
2017
Q3
$32.1M Buy
412,410
+8,656
+2% +$719K 0.71% 19
2017
Q2
$35.8M Sell
403,754
-80,124
-17% -$6.76M 0.79% 18
2017
Q1
$39M Buy
483,878
+473,401
+4,518% +$37M 0.31% 76
2016
Q4
$1.03M Buy
10,477
+239
+2% +$18.8K 0.01% 572
2016
Q3
$885K Sell
10,238
-341,885
-97% -$29.8M 0.01% 580
2016
Q2
$30.3M Buy
352,123
+25,423
+8% +$2.06M 0.33% 73
2016
Q1
$24.5M Buy
326,700
+315,703
+2,871% +$23.8M 0.27% 85
2015
Q4
$846K Buy
10,997
+361
+3% +$27.2K 0.01% 600
2015
Q3
$712K Buy
10,636
+2,089
+24% +$154K 0.01% 580
2015
Q2
$633K Sell
8,547
-60,817
-88% -$4.65M 0.01% 529
2015
Q1
$7.08M Sell
69,364
-328,796
-83% -$24.9M 0.06% 294
2014
Q4
$28.7M Sell
398,160
-110,270
-22% -$7.66M 0.27% 76
2014
Q3
$31.5M Sell
508,430
-390,961
-43% -$24.9M 0.31% 62
2014
Q2
$57.3M Sell
899,391
-47,495
-5% -$2.89M 0.55% 34
2014
Q1
$58.3M Buy
946,886
+62,717
+7% +$3.65M 0.62% 34
2013
Q4
$50.7M Sell
884,169
-109,231
-11% -$6.19M 0.58% 34
2013
Q3
$52.9M Buy
993,400
+188,991
+23% +$10.2M 0.66% 31
2013
Q2
$39.2M Buy
+804,409
New +$39.8M 0.6% 38

Other funds holding MDT

Westpac Banking Corp's MDT Position: Q1 2026 in Review

Westpac Banking Corp reduced its Medtronic (MDT) stake by 6.7% in Q1 2026, selling an estimated $269K and leaving 38,870 shares worth $3.37M. The position accounts for 0.23% of the portfolio, ranked #105.

Westpac Banking Corp first reported a position in MDT in Q2 2013 and has held it in 41 quarters since. The position peaked at $58.3M in Q1 2014. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Westpac Banking Corp held 38,870 shares of Medtronic worth $3.37M as of Q1 2026.
  • Westpac Banking Corp sold 2,811 Medtronic shares in Q1 2026, an estimated $269K.
  • Medtronic made up 0.23% of Westpac Banking Corp's portfolio in Q1 2026, its #105 holding.
  • Westpac Banking Corp first reported a position in Medtronic in Q2 2013 and has held it in 41 quarters since.
  • Westpac Banking Corp's Medtronic position peaked at $58.3M in Q1 2014.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.